BioLargo Net Profit Margin 2010-2024 | BLGO

BioLargo net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
BioLargo Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $0.02B $-0.00B -11.11%
2024-06-30 $0.02B $-0.00B -11.76%
2024-03-31 $0.01B $-0.00B -23.08%
2023-12-31 $0.01B $-0.00B -25.00%
2023-09-30 $0.01B $-0.00B -30.00%
2023-06-30 $0.01B $-0.00B -33.33%
2023-03-31 $0.01B $-0.00B -33.33%
2022-12-31 $0.01B $-0.01B -83.33%
2022-09-30 $0.01B $-0.01B -140.00%
2022-06-30 $0.00B $-0.01B -175.00%
2022-03-31 $0.00B $-0.01B -266.67%
2021-12-31 $0.00B $-0.01B -266.67%
2021-09-30 $0.00B $-0.01B -233.33%
2021-06-30 $0.00B $-0.01B -266.67%
2021-03-31 $0.00B $-0.01B -266.67%
2020-12-31 $0.00B $-0.01B -400.00%
2020-09-30 $0.00B $-0.01B -450.00%
2020-06-30 $0.00B $-0.01B -550.00%
2020-03-31 $0.00B $-0.01B -550.00%
2019-12-31 $0.00B $-0.01B -600.00%
2019-09-30 $0.00B $-0.01B -1100.00%
2019-06-30 $0.00B $-0.01B inf%
2019-03-31 $0.00B $-0.01B inf%
2018-12-31 $0.00B $-0.01B inf%
2018-09-30 $0.00B $-0.01B inf%
2018-06-30 $0.00B $-0.01B inf%
2018-03-31 $0.00B $-0.01B inf%
2017-12-31 $0.00B $-0.01B inf%
2017-09-30 $0.00B $-0.01B inf%
2017-06-30 $0.00B $-0.01B inf%
2017-03-31 $0.00B $-0.01B inf%
2016-12-31 $0.00B $-0.01B inf%
2016-09-30 $0.00B $-0.01B inf%
2016-06-30 $0.00B $-0.01B inf%
2016-03-31 $0.00B $-0.01B inf%
2015-12-31 $0.00B $-0.01B inf%
2015-09-30 $0.00B $-0.01B inf%
2015-06-30 $0.00B $-0.00B inf%
2015-03-31 $0.00B $-0.00B inf%
2014-12-31 $0.00B $-0.00B inf%
2014-09-30 $0.00B $-0.00B inf%
2014-06-30 $0.00B $-0.00B inf%
2014-03-31 $0.00B $-0.00B inf%
2013-12-31 $0.00B $-0.00B inf%
2013-09-30 $0.00B $-0.01B inf%
2013-06-30 $0.00B $-0.01B inf%
2013-03-31 $0.00B $-0.01B inf%
2012-12-31 $0.00B $-0.01B inf%
2012-09-30 $0.00B $-0.01B inf%
2012-06-30 $0.00B $-0.01B inf%
2012-03-31 $0.00B $-0.00B inf%
2011-12-31 $0.00B $-0.00B inf%
2011-09-30 $0.00B $-0.00B inf%
2011-06-30 $0.00B $-0.00B inf%
2011-03-31 $0.00B $-0.00B inf%
2010-12-31 $0.00B $-0.01B inf%
2010-09-30 $0.00B $-0.01B inf%
2010-06-30 $0.00B $-0.02B inf%
Sector Industry Market Cap Revenue
Construction Engineering - Research & Development Services $0.080B $0.012B
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
Stock Name Country Market Cap PE Ratio
Quanta Services (PWR) United States $45.919B 42.38
Alfa Laval AB (ALFVY) Sweden $17.765B 25.43
AECOM (ACM) United States $14.361B 22.65
Spirax Group (SPXSY) United Kingdom $14.327B 0.00
Fluor (FLR) United States $8.370B 19.44
KBR (KBR) United States $7.248B 17.38
Amentum Holdings (AMTM) United States $5.557B 0.00
ChampionX (CHX) United States $5.447B 15.77
Arcadis (ARCAY) Netherlands $4.949B 0.00
Sterling Infrastructure (STRL) United States $4.556B 24.98
Babcock Group (BCKIY) United Kingdom $3.342B 0.00
VSE (VSEC) United States $2.163B 0.00
Chiyoda (CHYCY) Japan $0.440B 13.08
TSS (TSSI) United States $0.355B 82.50
Mayville Engineering (MEC) United States $0.330B 27.10
Skyline Builders (SKBL) Hong Kong, SAR China $0.141B 0.00
WANG & LEE GROUP (WLGS) Hong Kong, SAR China $0.140B 0.00
Magnera (MAGN) United States $0.071B 0.00
Harris & Harris (TURN) United States $0.040B 0.00
SKK Holdings (SKK) Singapore $0.015B 0.00
SUs (SUGP) Hong Kong, SAR China $0.013B 0.00
CEA Industries (CEAD) United States $0.006B 0.00